Bright Green Announces First Quarter 2023 Financial Update and Milestone Progress
May 24, 2023 08:00 ET
|
Bright Green Corporation
Bright Green has achieved several key milestones throughout the Quarter significantly advancing progress against its strategic plan, including a historic DEA Federal Registration and License Approval....
Bright Green Announces Pricing of $3.5 Million Private Placement
May 22, 2023 08:00 ET
|
Bright Green Corporation
GRANTS, N.M., May 22, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow,...
Bright Green Announces the Launch of Its EB-5 Website and Program Following the Historic Announcement of Its Federal Registration and License Approval from the U.S. Drug Enforcement Administration
May 03, 2023 09:20 ET
|
Bright Green Corporation
Bright Green, the first publicly traded company in the U.S. to be federally authorized to grow, manufacture and sell cannabis and cannabis-related products for research, pharmaceutical and medical...
Bright Green Announces Historic Federal Registration and License Approval from the U.S. Drug Enforcement Administration Confirming Bright Green as a Bulk Manufacturer of Cannabis
May 01, 2023 08:30 ET
|
Bright Green Corporation
Bright Green is now the first publicly traded company, and the largest, in the U.S. to be federally authorized to grow, manufacture and sell cannabis and cannabis-related products for research,...
Bright Green Announces Fourth Quarter 2022 Financial Update
April 18, 2023 08:30 ET
|
Bright Green Corporation
Continued investment to support long-term strategy and pathway for growth, including plans to fully acquire Alterola Biotech, appointment of Seamus McAuley as Chief Executive Officer and expansion of...
Bright Green Announces Decision to Complete Alterola Biotech Acquisition
April 04, 2023 08:30 ET
|
Bright Green Corporation
Bright Green to acquire remaining 75% of Alterola common stock Agreements and completion will be subject to customary conditions and regulatory and stockholder approvals Alterola will support...
Bright Green Responds to False Claims Made Against the Company
February 21, 2023 08:30 ET
|
Bright Green Corporation
Denies any association with John Fikany and Jerry Capussi and categorically refutes the insinuations made on behalf of these individuals Company requesting immediate retraction while reserving the...
Bright Green Announces the Receipt of Its First Funds from Its EB-5 Program
February 13, 2023 08:30 ET
|
Bright Green Corporation
News reinforces Bright Green’s plans to build additional new facilities in Grants, New Mexico, and confirms final requirements and amendments to certificate of occupancy for existing one million...
Bright Green Announces Appointment of Seamus McAuley, Chief Operating Officer of Bright Green, as Chief Executive Officer
February 09, 2023 08:30 ET
|
Bright Green Corporation
Terry Rafih to remain as Executive Chairman of the BoardAppointment reinforces Company’s strategy to build out its team to deliver on the development of cannabis-based medicines and products, as well...
Bright Green Issues Statement of Intent on Illegal Short Selling Activities
February 03, 2023 12:21 ET
|
Bright Green Corporation
GRANTS, N.M., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow,...